Table 3.
EU5 aggregate and country-specific data: list/net pharmaceutical expenditure compound annual growth rates (2010–2021)
CAGR (%) | ||
---|---|---|
List | Net | |
France | ||
Historical (2010–2016) | 0.5 | − 0.4 |
Forecast (2017–2021) | 1.8 | 0.6 |
Germany | ||
Historical (2010–2016) | 3.9 | 2.5 |
Forecast (2017–2021) | 3.2 | 2.0 |
Italy | ||
Historical (2010–2016) | 4.5 | 2.8 |
Forecast (2017–2021) | 3.2 | 1.1 |
Spain | ||
Historical (2010–2016) | 2.2 | NC |
Historical (2014–2016) | 9.4 | 4.8 |
Forecast (2017–2021) | 2.5 | 1.1 |
UK | ||
Historical (2010–2016) | 6.8 | NC |
Historical (2013–2016) | 7.9 | 4.3 |
Forecast (2017–2021) | 3.8 | 2.3 |
EU5 | ||
Historical (2010–2016) | 3.4 | 2.0 |
Forecast (2017–2021) | 2.9 | 1.5 |
CAGRs compound annual growth rates, NC could not be calculated because of lack of data